Elligo Health Research is a clinical trial technology company offering a modular clinical trial management system, along with research support services and tools. The company primarily focuses on tailoring the clinical trial process to improve site recruitment and the patient journey, including wider patient diversity. The company's proprietary modules include 1) Intelligo Research Stack - connects the company’s patient and research database with the system, 2) ResearchConnect Network - a database with over 150 million patients as of August 2022 and third-party partners, and 3) Root - a digital buddy for patient support and reminders. From a regulatory standpoint, the platform and database is HIPAA compliant.
Key customers and partnerships
In May 2022, the company announced a collaboration with Cerner Corporation and Freenome, to enable a cancer screening clinical trial through Cerner’s Learning Health Network platform.
More recently, in December 2023, the company partnered with contract research organization Catawba Research to expand access to clinical trials and simplify clinical research participation. Through the partnership, all of Catawba’s clinical studies were made available through Elligo’s 'Study Marketplace' platform to drive participation and increase efficiencies for research sites and sponsors.
Funding and financials
The company raised USD 135 million in Series E funding in Series A funding in September 2021, led by Morgan Stanley and Ally Bridge. The proceeds are to be used to fund the acquisition of ClinEdge and invest in development of the technology and data platform.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.